Suppr超能文献

基于 DNA 甲基化对肝癌的免疫细胞组成和生物年龄进行去卷积分析。

Deconvolution of immune cell composition and biological age of hepatocellular carcinoma using DNA methylation.

机构信息

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

出版信息

Methods. 2023 Oct;218:125-132. doi: 10.1016/j.ymeth.2023.08.004. Epub 2023 Aug 11.

Abstract

Hepatocellular carcinoma (HCC) has been an approved indication for the administration of immunotherapy since 2017, but biomarkers that predict therapeutic response have remained limited. Understanding and characterizing the tumor immune microenvironment enables better classification of these tumors and may reveal biomarkers that predict immunotherapeutic efficacy. In this paper, we applied a cell-type deconvolution algorithm using DNA methylation array data to investigate the composition of the tumor microenvironment in HCC. Using publicly available and in-house datasets with a total cohort size of 57 patients, each with tumor and matched normal tissue samples, we identified key differences in immune cell composition. We found that NK cell abundance was significantly decreased in HCC tumors compared to adjacent normal tissue. We also applied DNA methylation "clocks" which estimate phenotypic aging and compared these findings to expression-based determinations of cellular senescence. Senescence and epigenetic aging were significantly increased in HCC tumors, and the degree of age acceleration and senescence was strongly associated with decreased NK cell abundance. In summary, we found that NK cell infiltration in the tumor microenvironment is significantly diminished, and that this loss of NK abundance is strongly associated with increased senescence and age-related phenotype. These findings point to key interactions between NK cells and the senescent tumor microenvironment and offer insights into the pathogenesis of HCC as well as potential biomarkers of therapeutic efficacy.

摘要

肝细胞癌 (HCC) 自 2017 年以来已被批准用于免疫治疗,但预测治疗反应的生物标志物仍然有限。了解和描述肿瘤免疫微环境可以更好地对这些肿瘤进行分类,并可能揭示预测免疫治疗疗效的生物标志物。在本文中,我们应用基于 DNA 甲基化阵列数据的细胞类型去卷积算法来研究 HCC 中肿瘤微环境的组成。使用包含 57 名患者的总队列大小的公开可用和内部数据集,每个患者均具有肿瘤和匹配的正常组织样本,我们确定了免疫细胞组成的关键差异。我们发现与相邻正常组织相比,NK 细胞在 HCC 肿瘤中的丰度显着降低。我们还应用了估计表型衰老的 DNA 甲基化“时钟”,并将这些发现与基于表达的细胞衰老测定进行了比较。衰老和表观遗传衰老在 HCC 肿瘤中显着增加,衰老加速的程度与 NK 细胞丰度的降低强烈相关。总之,我们发现肿瘤微环境中的 NK 细胞浸润明显减少,这种 NK 丰度的丧失与衰老和与年龄相关的表型增加密切相关。这些发现指出了 NK 细胞与衰老的肿瘤微环境之间的关键相互作用,并为 HCC 的发病机制以及治疗疗效的潜在生物标志物提供了见解。

相似文献

本文引用的文献

2
Exploiting senescence for the treatment of cancer.利用衰老治疗癌症。
Nat Rev Cancer. 2022 Jun;22(6):340-355. doi: 10.1038/s41568-022-00450-9. Epub 2022 Mar 3.
4
Immunotherapies for hepatocellular carcinoma.肝细胞癌的免疫疗法
Nat Rev Clin Oncol. 2022 Mar;19(3):151-172. doi: 10.1038/s41571-021-00573-2. Epub 2021 Nov 11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验